We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 62 start-ups with an aggregate funding of $8.1b. The average funding per company in this subset is $131.4m.
Last update to the database: Jun 3, 2025. See changelog.
5
Funding Rounds
$263.1m
Money raised
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.
2
Funding Rounds
$120.0m
Money raised
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
8
Funding Rounds
$117.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
10
Funding Rounds
$87.6m
Money raised
Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.
16
Funding Rounds
$328.8m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
6
Funding Rounds
$4.6m
Money raised
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
8
Funding Rounds
$459.7m
Money raised
Silicon Valley-based genetic engineering startup.
9
Funding Rounds
$262.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
4
Funding Rounds
$153.5m
Money raised
Sherlock Biosciences is a Cambridge, Massachusetts-based company founded in 2019 by David R. Walt, Rahul Dhanda, Feng Zhang, Jim Collins, Deborah Hung, Jonathan Gootenberg, Omar Abudayyeh, Pardis Sabeti and Todd Golub.
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
6
Funding Rounds
$41.3m
Money raised
Beta Hatch is an insect protein for farming company founded in 2015 by Virginia Emery.
7
Funding Rounds
$31.4m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
13
Funding Rounds
$677.0m
Money raised
A gene editing technology company founded in 2015 and based in Boulder, CO, USA.
5
Funding Rounds
$30.9m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
2
Funding Rounds
$100.0m
Money raised
Snipr Biome is a synthetic biology company using CRISPR to make products for the microbiome.
3
Funding Rounds
$600.0k
Money raised
Caspr Biotech is developing a CRISPR-based platform for rapid diagnostic systems for viruses, bacteria and genetic mutations
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$33.9m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
11
Funding Rounds
$67.4m
Money raised
Recombinetics is a biotechnology company that uses gene editing for agriculture and medicine
3
Funding Rounds
$200.0m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$70.8m
Money raised
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia.
3
Funding Rounds
$3.5m
Money raised
enEvolv is a Medford, Massachusetts-based biological product manufacturer.
1
Funding Rounds
$215.0m
Money raised
Arbor Technologies is a company in Cambridge, MA, focusing on biodiscovery using machine learning, genome sequencing, gene synthesis and high-throughput screening.
2
Funding Rounds
$5.2m
Money raised
Agragene develops sterile male insects to replace chemical pesticides for the control of crop pests
3
Funding Rounds
$45.5m
Money raised
JumpCode Genomics develops NGS solutions for the oncology, infectious disease, basic research, and consumer genomics fields.
2
Funding Rounds
$115.0m
Money raised
Pairwise uses CRISPR, gene editing and natural diversity in agricultural crops to address global food challenges. The company is working to develop new varieties of crops.
3
Funding Rounds
$34.5m
Money raised
GenEdit develops technology for gene editing.
2
Funding Rounds
$156.0m
Money raised
KSQ Therapeutics is a Cambridge, Massachusetts-based company in the pharmaceuticals industry founded in 2015.
2
Funding Rounds
$97.5m
Money raised
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
2
Funding Rounds
$7.4m
Money raised
Blue Heron Biotechnology Inc is company that provides synthetic DNA sequences and related services to the pharmaceutical and biotechnology companies
5
Funding Rounds
$298.0m
Money raised
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
4
Funding Rounds
$210.6m
Money raised
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.
4
Funding Rounds
$38.5m
Money raised
Tropic Biosciences is a genome editing company founded in 2016 by Gilad Gershon.
4
Funding Rounds
$7.8m
Money raised
Canopy Biosciences is a company that aims to increase the commercialization of life science reagent tools and services via in-licensing key technologies.
1
Funding Rounds
Biotech company developing technologies to improve efficiency and safety of CRISPR-Cas gene editing through anti-CRISPR proteins, also known as Acr proteins
2
Funding Rounds
$5.8m
Money raised
Phytoform Labs is a biotechnology company.
2
Funding Rounds
$695.0m
Money raised
ElevateBio is a company founded by Vikas Sinha, David Hallal and Melissa Carpenter.
1
Funding Rounds
$172.0m
Money raised
Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
2
Funding Rounds
$34.0m
Money raised
CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.
3
Funding Rounds
$16.1m
Money raised
Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases.
2
Funding Rounds
$260.0m
Money raised
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
1
Funding Rounds
$70.5m
Money raised
Ensoma, Inc. is an in vivo Gene Therapy founded in 2019.
2
Funding Rounds
$60.0m
Money raised
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
4
Funding Rounds
$89.0m
Money raised
Latch Bio is a San Francisco-based company founded by Kyle Giffin, Kenny Workman and Alfredo Andere.
3
Funding Rounds
$117.5m
Money raised
Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
1
Funding Rounds
$40.0m
Money raised
Watchmaker Genomics applies enzymology to enable applications for reading, writing and editing DNA.
1
Funding Rounds
$1.6m
Money raised
Cultured Decadence is a Wisconsin-based cellular agriculture company using cell culture and tissue engineering technologies to make lobster meat directly from the animal's cells. The company was acquired by Upside Foods in January 2022.
2
Funding Rounds
$315.0m
Money raised
Prime Medicine is a gene Editing Technology founded in 2019 by David R. Liu.
1
Funding Rounds
$14.0m
Money raised
Hui-Gene Therapeutics is a company founded in 2018 by Xuan Yao.
2
Funding Rounds
$530.0m
Money raised
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
2
Funding Rounds
$175.0m
Money raised
Metagenomi is a Gene-Edited Microbial Treatments.
2
Funding Rounds
$29.5m
Money raised
ONK Therapeutics is a natural Killer Cell Therapies founded in 2015.
2
Funding Rounds
$35.0m
Money raised
SeQure Dx is a diagnostics company specializing in gene-editing.
1
Funding Rounds
$45.0m
Money raised
Proof Diagnostics is harnessing CRISPR technology to unlock powerful molecular diagnostics for all, starting with COVID-19 testing.
1
Funding Rounds
$175.0m
Money raised
Affini-T Therapeutics, Inc is a TCR Cell Therapy.
1
Funding Rounds
$87.0m
Money raised
Clade Therapeutics is a stem Cell Therapies founded by Jim Glasheen, Chad Cowan and Leandro Vetcher.
2
Funding Rounds
$30.0m
Money raised
Avectas is a Non-Viral Cell Manufacturing Technology.
1
Funding Rounds
$55.0m
Money raised
Epic Bio is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.
1
Funding Rounds
$50.0m
Money raised
iECURE is a gene Editing Therapies.
1
Funding Rounds
$140.0m
Money raised
1
Funding Rounds
$80.0m
Money raised
1
Funding Rounds
$4.0m
Money raised
CRISPRQC INC. is a quality Control for CRISPR founded in 2021.
Enter your email and get access to 71,000 + technology companies you can partner with.